Ren P - Search Results

1

Pseudolaric acid B inhibits the secretion of hepatitis B virus.

Yu J, Wang Z, Ren P, Zhong T, Wang Y, Song F, Hou J, Yu X, Hua S. Yu J, et al. Among authors: ren p. Oncol Rep. 2017 Jan;37(1):519-525. doi: 10.3892/or.2016.5254. Epub 2016 Nov 16. Oncol Rep. 2017. PMID: 27878296

2

Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo.

Liu J, Dong BF, Wang PS, Ren PY, Xue S, Zhang XΝ, Han Z, Chen G. Liu J, et al. Oncol Rep. 2015 Mar;33(3):1551-9. doi: 10.3892/or.2015.3730. Epub 2015 Jan 15. Oncol Rep. 2015. Retraction in: Oncol Rep. 2022 May;47(5):86. doi: 10.3892/or.2022.8297 PMID: 25592304 Retracted.

3

Enterovirus 71 mediates cell cycle arrest in S phase through non-structural protein 3D.

Yu J, Zhang L, Ren P, Zhong T, Li Z, Wang Z, Li J, Liu X, Zhao K, Zhang W, Yu XF. Yu J, et al. Among authors: ren p. Cell Cycle. 2015;14(3):425-36. doi: 10.4161/15384101.2014.980631. Cell Cycle. 2015. PMID: 25659038 Free PMC article.

4

Pseudolaric acid B inhibits proliferation in SW579 human thyroid squamous cell carcinoma.

Yu J, Ren P, Zhong T, Wang Y, Yan M, Xue B, Li R, Dai C, Liu C, Chen G, Yu XF. Yu J, et al. Among authors: ren p. Mol Med Rep. 2015 Nov;12(5):7195-202. doi: 10.3892/mmr.2015.4418. Epub 2015 Oct 5. Mol Med Rep. 2015. PMID: 26460192 Free PMC article.

5

MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.

Dong S, Jin M, Li Y, Ren P, Liu J. Dong S, et al. Among authors: ren p. Oncol Rep. 2016 Apr;35(4):2151-8. doi: 10.3892/or.2016.4604. Epub 2016 Feb 1. Oncol Rep. 2016. Retraction in: Oncol Rep. 2021 Sep;46(3):206. doi: 10.3892/or.2021.8157 PMID: 26847706 Retracted.

6

[Retracted] miR‑137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.

Dong S, Jin M, Li Y, Ren P, Liu J. Dong S, et al. Among authors: ren p. Oncol Rep. 2021 Sep;46(3):206. doi: 10.3892/or.2021.8157. Epub 2021 Jul 28. Oncol Rep. 2021. PMID: 34318908 Free PMC article.

7

[Retracted] Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo.

Liu J, Dong BF, Wang PS, Ren PY, Xue S, Zhang XN, Han Z, Chen G. Liu J, et al. Oncol Rep. 2022 May;47(5):86. doi: 10.3892/or.2022.8297. Epub 2022 Mar 2. Oncol Rep. 2022. PMID: 35234269 Free PMC article.

8

Short and Long-Term Potential Role of Carbon Nanoparticles in Total Thyroidectomy with Central Lymph Node Dissection.

Xue S, Ren P, Wang P, Chen G. Xue S, et al. Among authors: ren p. Sci Rep. 2018 Aug 9;8(1):11936. doi: 10.1038/s41598-018-30299-8. Sci Rep. 2018. PMID: 30093623 Free PMC article.

9

microRNA-141 inhibits thyroid cancer cell growth and metastasis by targeting insulin receptor substrate 2.

Dong S, Meng X, Xue S, Yan Z, Ren P, Liu J. Dong S, et al. Among authors: ren p. Am J Transl Res. 2016 Mar 15;8(3):1471-81. eCollection 2016. Am J Transl Res. 2016. PMID: 27186273 Free PMC article.

10

MicroRNA-363-3p inhibits papillary thyroid carcinoma progression by targeting PIK3CA.

Liu J, Li Q, Li R, Ren P, Dong S. Liu J, et al. Among authors: ren p. Am J Cancer Res. 2017 Jan 1;7(1):148-158. eCollection 2017. Am J Cancer Res. 2017. Retraction in: Am J Cancer Res. 2022 Aug 15;12(8):4082. PMID: 28123856 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,969 results

Search Page

Filters